Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in JapanSatoshi Watanabe, Tomohide Tamura, Hiroshige Yoshioka et al.|Lung Cancer|2019Cited by 38
Deep learning and digital pathology powers prediction of HCC development in steatotic liver diseaseT. Nakatsuka, Kazuhiko Koike, Ami Kamada et al.|Hepatology|2024Cited by 35